
12.00 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 5.91 Today|||52-Week Range 12.76 | +3.90% Year-to-Date |
The 10 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 14.50, with a high estimate of 20.00 and a low estimate of 10.00. The median estimate represents a +20.83% increase from the last price of 12.00.
The current consensus among 12 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.